Patent · US Expired

Inhibitors of factor Xa

US6545055B1 · kind B1 · utility

15Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2000
Grant dateApr 8, 2003
Priority date
Expiry dateMay 24, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C311/46
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.